Lenalidomide in combination with an activin A-neutralizing antibody: preclinical rationale for a novel anti-myeloma strategy.

Saved in:
Bibliographic Details
Title: Lenalidomide in combination with an activin A-neutralizing antibody: preclinical rationale for a novel anti-myeloma strategy.
Authors: Scullen, T1, Santo, L1, Vallet, S1, Fulciniti, M2, Eda, H1, Cirstea, D3, Patel, K1, Nemani, N1, Yee, A1, Mahindra, A1, Raje, N1
Source: Leukemia (08876924). Aug2013, Vol. 27 Issue 8, p1715-1721. 7p. 5 Graphs.
Database: Academic Search Ultimate
Description
ISSN:08876924
DOI:10.1038/leu.2013.50